Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 18.0B | 8.0B | 5.4B | 1.9B |
Cost of revenue | 10.5B | 3.7B | 2.2B | 322.5M |
Gross profit | 7.5B | 4.3B | 3.1B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.9B | 2.1B | 802.8M | 641.5M |
Operating income | 2.8B | 1.1B | 811.7M | -679.9M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 7.1M | 7.1M | 7.3M | 11.6M |
Other income expense | — | — | — | — |
Pretax income | 3.8B | 1.9B | 1.7B | 112.3M |
Tax provision | 1.1B | 457.6M | 439.4M | 40.2M |
Net income | 2.7B | 1.5B | 1.2B | 72.2M |
Basic EPS | — | 4.0 | 3.3 | 0.2 |
Diluted EPS | — | 4.0 | 3.3 | 0.2 |
Basic average shares | — | 366.9M | 366.9M | 360.8M |
Diluted average shares | — | 366.9M | 366.9M | 360.8M |
EBITDA | 4.0B | 2.1B | 1.8B | 280.6M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |